BioCentury | Feb 29, 2016
Finance

Full-spectrum investing

...CFO at Amgen Inc. (NASDAQ:AMGN) and Novartis AG (NYSE:NVS; SIX:NOVN). Evans is also chairman of Arthurian Life Sciences...
BioCentury | Jul 29, 2013
Finance

Alive and Welsh

...the Wales Life Sciences Investment Fund, which is managed by Sir Chris Evans' investment firm Arthurian Life Sciences...
BioCentury | Jul 29, 2013
Company News

ReNeuron board of directors update

...ReNeuron Group plc (LSE:RENE), Guildford, U.K. Business: Neurology Appointed: Sir Chris Evans, chairman of Arthurian Life Sciences WIR Staff...
BioCentury | Jul 22, 2013
Financial News

ReNeuron to raise L25.4 million

...a new facility in and relocate to Wales. Sir Chris Evans, chairman of investment firm Arthurian Life Sciences...
BioCentury | May 27, 2013
Finance

Demand disequilibrium

...Sep-12 Wellington Partners Wellington Partners IV Life Science Fund Germany; Switzerland; U.K. $157 (target) Mar-12 Arthurian Life Sciences...
BioCentury | Feb 4, 2013
Finance

Wale(s) of experience

...former executives surfaced last week as board members of Sir Chris Evans' new investment firm Arthurian Life Sciences...
Items per page:
1 - 6 of 6
BioCentury | Feb 29, 2016
Finance

Full-spectrum investing

...CFO at Amgen Inc. (NASDAQ:AMGN) and Novartis AG (NYSE:NVS; SIX:NOVN). Evans is also chairman of Arthurian Life Sciences...
BioCentury | Jul 29, 2013
Finance

Alive and Welsh

...the Wales Life Sciences Investment Fund, which is managed by Sir Chris Evans' investment firm Arthurian Life Sciences...
BioCentury | Jul 29, 2013
Company News

ReNeuron board of directors update

...ReNeuron Group plc (LSE:RENE), Guildford, U.K. Business: Neurology Appointed: Sir Chris Evans, chairman of Arthurian Life Sciences WIR Staff...
BioCentury | Jul 22, 2013
Financial News

ReNeuron to raise L25.4 million

...a new facility in and relocate to Wales. Sir Chris Evans, chairman of investment firm Arthurian Life Sciences...
BioCentury | May 27, 2013
Finance

Demand disequilibrium

...Sep-12 Wellington Partners Wellington Partners IV Life Science Fund Germany; Switzerland; U.K. $157 (target) Mar-12 Arthurian Life Sciences...
BioCentury | Feb 4, 2013
Finance

Wale(s) of experience

...former executives surfaced last week as board members of Sir Chris Evans' new investment firm Arthurian Life Sciences...
Items per page:
1 - 6 of 6